IncFact
Company Profiles: Revenue, Growth, Competition

Supernus Pharmaceuticals Revenue, Growth & Competitor Profile

Last updated:

Company Awards

 
Public Company
public company
Fast Growing
Fastest Growing
Big Fish
Big Fish
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Supernus Pharmaceuticals

Access the complete profile.

Supernus Pharmaceuticals Fast Facts

RevenueOver $500 million    See Exact Annual Revenue
Employees500 - 1,000Exact Company Size
Primary Industry325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes325412 Pharmaceutical Preparation Manufacturing
5417 Scientific Research & Development Services
Address9715 Key W Ave
Rockville, MD 20850

Note: Revenues for privately held companies are statistical evaluations.


Supernus Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?
    • Supernus Pharmaceuticals is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Supernus Pharmaceuticals Annual Revenue and Growth Rate

Supernus Pharmaceuticals Revenue Est.
($ Million)
Growth Rate (%)# Employees
2023 Over $500 million

Details in Premium Report
2022
2021
2020
2019


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Supernus Pharmaceuticals's revenues are gauged from an analysis of company filings.



Supernus Pharmaceuticals's Income Statement (based on Industry Averages)

Supernus Pharmaceuticals P&L$ Millions
Revenue (Sales) Supernus Pharmaceuticals Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Trademark Applications

Trademark applications show the products and services that Supernus Pharmaceuticals is developing and marketing. Supernus Pharmaceuticals doesn't have any recent trademark applications, indicating Supernus Pharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES
Pharmaceutical preparations for therapeutic use in humans, namely, for the treatment and prevention of central nervous system and peripheral nervous system diseases and disorders, psychiatric and neurological diseases and disorders; all containing Viloxazine
10/29/2020
ONCE-A-DAY QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG
Pharmaceutical preparations for therapeutic use in humans, namely, for the treatment and prevention of central nervous system and peripheral nervous system diseases and disorders, psychiatric and neurological diseases and disorders; all containing Viloxazine
10/29/2020
ONCE-DAILY QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG
Pharmaceutical preparations for therapeutic use in humans, namely, for the treatment and prevention of central nervous system and peripheral nervous system diseases and disorders, psychiatric and neurological diseases and disorders; all containing Viloxazine
10/29/2020

See all trademarks and details in the Full Report.


Market Share of Supernus Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Supernus Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
XYMOGENOrlando, FL100 
AVANTI NUTRITIONAL LABORATORIESMiami Lakes, FL37 
NUTRITION FORMULATORSMiramar, FL36 
RTPRCabot, AR33 
INTEGRATED BOTANICSFort Worth, TX29 
COSMAX NBT USAGarland, TX29 
CJB INDUSTRIESValdosta, GA28 
ALTERNATIVE LABORATORIESNaples, FL28 
S&B PHARMAAzusa, CA28 




Nearby Competitors

These companies are similar in business line and location to Supernus Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
EMERGENT BIOSOLUTIONSGaithersburg, MD100 
SUPERNUS PHARMACEUTICALSRockville, MD62 
AURINIA PHARMA USRockville, MD28 
VIGENE BIOSCIENCESRockville, MD15 
ORIGENE TECHNOLOGIESRockville, MD13 
NEUMODXGermantown, MD13 




Future Competition: Supernus Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Supernus Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Supernus Pharmaceuticals Competitors